Patients' and Physicians' Perspectives on the Management of Prolactinomas: Experiences, Treatment Preferences, and Related Outcomes - The PROMISE Survey
Status: Active_not_recruiting
Location: See location...
Study Type: Observational
SUMMARY
The PROMISE Survey was developed to systematically assess the real-world experiences, treatment preferences, side effects, and outcomes from both patients and physicians dealing with prolactinomas. The aim is to generate insights that can guide future clinical research and improve individualized care strategies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Prolactinoma patients
• Prolactinoma treating physicians including endocrinologists and neurosurgeons
Locations
Other Locations
Switzerland
University Hospital Basel
Basel
Time Frame
Start Date: 2025-06-13
Completion Date: 2026-03-30
Participants
Target number of participants: 530
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland